Author Archives: Priya Kathpalia, Sunanda Kane, Uma Mahadevan

Detectable Drug Levels in Infants Exposed to Biologics: So What?

Two-thirds of patients with active inflammatory bowel disease (IBD) at the time of conception will either continue to suffer active symptoms or worsen.1,2 Therefore, we strive to achieve remission in women of childbearing potential before conception. M… Continue reading

Posted in News | Comments Off on Detectable Drug Levels in Infants Exposed to Biologics: So What?